AJP - Regulatory, Integrative and Comparative Physiology, Vol 266, Issue 3 809-R816, Copyright © 1994 by American Physiological Society

ARTICLES

Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans

D. Randin, P. Vollenweider, L. Tappy, E. Jequier, P. Nicod and U. Scherrer
Department of Internal Medicine B, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Euglycemic hyperinsulinemia stimulates both sympathetic nerve activity and blood flow to skeletal muscle, but the mechanism is unknown. Possible mechanisms that may stimulate muscle blood flow include neural, humoral, or metabolic effects of insulin. To determine whether such insulin-induced vasodilation is modulated by stimulation of adrenergic or cholinergic mechanisms, we obtained, in eight healthy lean subjects, plethysmographic measurements of calf blood flow during 3 h of hyperinsulinemic (1 mU.kg-1.min-1) euglycemic clamp performed alone or during concomitant beta-adrenergic (propranolol infusion), cholinergic (atropine infusion), or alpha-adrenergic (prazosin administration) blockade. Euglycemic hyperinsulinemia alone increased calf blood flow by 38 +/- 10% (means +/- SE) and decreased vascular resistance by 27 +/- 4% (P < 0.01). The principal new observation is that these insulin-induced vasodilatory responses were not attenuated by concomitant propranolol or atropine infusion, nor were they potentiated by prazosin administration. In conclusion, these findings provide evidence that during euglycemic hyperinsulinemia in lean healthy humans stimulation of muscle blood flow is not mediated primarily by beta-adrenergic or cholinergic mechanisms. Furthermore, alpha-adrenergic mechanisms do not markedly limit insulin-induced stimulation of muscle blood flow.

This article has been cited by other articles:

				M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258. [Abstract] [Full Text] [PDF]

				C. Sartori, L. Trueb, P. Nicod, and U. Scherrer Effects of Sympathectomy and Nitric Oxide Synthase Inhibition on Vascular Actions of Insulin in Humans Hypertension, October 1, 1999; 34(4): 586 - 589. [Abstract] [Full Text] [PDF]

				K. Masuo, H. Mikami, T. Ogihara, and M. L. Tuck Familial Hypertension, Insulin, Sympathetic Activity, and Blood Pressure Elevation Hypertension, July 1, 1998; 32(1): 96 - 100. [Abstract] [Full Text] [PDF]

				U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text]

				G. Lembo, G. Iaccarino, C. Vecchione, V. Rendina, L. Parrella, and B. Trimarco Insulin Modulation of ß-Adrenergic Vasodilator Pathway in Human Forearm Circulation, April 1, 1996; 93(7): 1403 - 1410. [Abstract] [Full Text]